Deuterium Capital Management LLC Acquires Shares of 10,000 Liquidia Co. (NASDAQ:LQDA)

Deuterium Capital Management LLC purchased a new stake in Liquidia Co. (NASDAQ:LQDA) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 10,000 shares of the company’s stock, valued at approximately $120,000.

A number of other large investors have also added to or reduced their stakes in LQDA. American International Group Inc. lifted its position in shares of Liquidia by 5.2% during the 1st quarter. American International Group Inc. now owns 24,806 shares of the company’s stock valued at $366,000 after acquiring an additional 1,215 shares during the period. Bleakley Financial Group LLC lifted its position in Liquidia by 6.6% during the first quarter. Bleakley Financial Group LLC now owns 33,250 shares of the company’s stock worth $490,000 after purchasing an additional 2,057 shares during the period. Hilltop National Bank acquired a new stake in Liquidia during the second quarter worth about $33,000. Price T Rowe Associates Inc. MD increased its holdings in Liquidia by 26.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 14,341 shares of the company’s stock valued at $212,000 after buying an additional 2,999 shares during the period. Finally, Advisory Services Network LLC increased its holdings in Liquidia by 17.9% in the 4th quarter. Advisory Services Network LLC now owns 43,535 shares of the company’s stock valued at $524,000 after buying an additional 6,600 shares during the period. Institutional investors and hedge funds own 64.54% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Raymond James raised shares of Liquidia from an “outperform” rating to a “strong-buy” rating in a report on Monday, August 19th. Oppenheimer assumed coverage on shares of Liquidia in a report on Tuesday, June 25th. They issued a “market perform” rating on the stock. BTIG Research decreased their target price on shares of Liquidia from $29.00 to $25.00 and set a “buy” rating on the stock in a report on Monday, August 19th. HC Wainwright decreased their target price on shares of Liquidia from $32.00 to $29.00 and set a “buy” rating on the stock in a report on Tuesday, August 20th. Finally, Bank of America decreased their target price on shares of Liquidia from $24.00 to $23.00 and set a “buy” rating on the stock in a report on Tuesday, August 20th. One research analyst has rated the stock with a sell rating, one has given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Liquidia presently has a consensus rating of “Moderate Buy” and a consensus price target of $23.14.

Insider Buying and Selling

In related news, CFO Michael Kaseta sold 3,906 shares of Liquidia stock in a transaction that occurred on Friday, July 12th. The shares were sold at an average price of $12.53, for a total transaction of $48,942.18. Following the sale, the chief financial officer now directly owns 312,389 shares in the company, valued at approximately $3,914,234.17. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, CEO Roger Jeffs sold 8,053 shares of the business’s stock in a transaction that occurred on Friday, July 12th. The shares were sold at an average price of $12.53, for a total value of $100,904.09. Following the transaction, the chief executive officer now owns 818,932 shares in the company, valued at approximately $10,261,217.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Michael Kaseta sold 3,906 shares of the business’s stock in a transaction that occurred on Friday, July 12th. The stock was sold at an average price of $12.53, for a total transaction of $48,942.18. Following the completion of the transaction, the chief financial officer now owns 312,389 shares in the company, valued at approximately $3,914,234.17. The disclosure for this sale can be found here. Insiders have sold a total of 21,437 shares of company stock worth $268,549 in the last ninety days. Company insiders own 31.60% of the company’s stock.

Liquidia Stock Performance

Shares of Liquidia stock traded down $0.03 during midday trading on Friday, hitting $9.51. 815,141 shares of the company traded hands, compared to its average volume of 998,645. The stock has a market cap of $726.70 million, a price-to-earnings ratio of -6.10 and a beta of 0.32. The firm’s fifty day moving average price is $11.56 and its 200-day moving average price is $13.05. Liquidia Co. has a 12 month low of $5.71 and a 12 month high of $16.99.

Liquidia (NASDAQ:LQDA) last announced its quarterly earnings results on Wednesday, August 7th. The company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.02). The company had revenue of $3.66 million for the quarter, compared to the consensus estimate of $7.92 million. Liquidia had a negative net margin of 674.42% and a negative return on equity of 177.83%. Equities research analysts forecast that Liquidia Co. will post -1.39 earnings per share for the current year.

Liquidia Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).